Jane Wasman
CIK 1352455 · President, Intl and GC · last filed 2026-05-19
Jane Wasman is a President, Intl and GC who has filed 87 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for RIGL, was dated May 19, 2026. Across all open-market trades the lifetime net is −$7.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.33M
4
87
-$7.66M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | Director | 18,250 | $32.85 | $599.5K | $0 | 9 | 2026-05-19 |
| SLS | Director | 92,900 | $7.83 | $727.4K | $33.8K | 11 | 2026-01-09 |
| ATHERSYS, INC / NEW (ATHX) Delisted | Director | 35,141 | $0.01 | $474 | $0 | 4 | 2023-01-11 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | President, Intl and GC | 117,420 | $0.66 | $77.6K | -$7.69M | 63 | 2019-12-04 |
Recent Filings
87 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-19 | RIGL | Grant (A) | +5,750 | $0 | EDGAR |
| 2026-01-09 | SLS | Grant (A) | +50,000 | $0 | EDGAR |
| 2025-06-02 | SLS | Buy (P) | +20,000 | $33.8K | EDGAR |
| 2025-05-28 | RIGL | Grant (A) | +2,500 | $0 | EDGAR |
| 2025-01-14 | SLS | Grant (A) | +12,500 | $0 | EDGAR |
| 2024-05-29 | RIGL | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-01-25 | SLS | Grant (A) | +6,000 | $0 | EDGAR |
| 2023-07-12 | RIGL | Grant (A) | +25,000 | $0 | EDGAR |
| 2023-02-03 | SLS | Grant (A) | +2,500 | $0 | EDGAR |
| 2023-01-11 | ATHERSYS, INC / NEW (ATHX) Delisted | Grant (A) | +22,321 | $0 | EDGAR |